AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,970,000 | -12.6% | 120,000 | 0.0% | 0.05% | -23.3% |
Q2 2023 | $3,398,400 | +29.7% | 120,000 | +5.2% | 0.06% | +17.6% |
Q1 2023 | $2,620,555 | +55.5% | 114,086 | +90.1% | 0.05% | +96.2% |
Q4 2022 | $1,684,800 | -58.9% | 60,000 | -58.6% | 0.03% | -54.4% |
Q3 2022 | $4,100,000 | -8.6% | 145,000 | -5.8% | 0.06% | +5.6% |
Q1 2022 | $4,484,000 | +4.1% | 154,000 | +17.6% | 0.05% | +12.5% |
Q4 2021 | $4,308,000 | -34.3% | 131,000 | +10.1% | 0.05% | -44.2% |
Q2 2021 | $6,560,000 | +62.9% | 119,000 | +52.6% | 0.09% | -1.1% |
Q1 2021 | $4,028,000 | -4.2% | 78,000 | -19.6% | 0.09% | -9.4% |
Q4 2020 | $4,204,000 | +13.2% | 97,000 | -8.5% | 0.10% | +11.6% |
Q3 2020 | $3,713,000 | -34.5% | 106,000 | 0.0% | 0.09% | -54.5% |
Q2 2020 | $5,671,000 | +188.2% | 106,000 | +91.0% | 0.19% | +70.3% |
Q1 2020 | $1,968,000 | -43.9% | 55,500 | -24.5% | 0.11% | -5.9% |
Q4 2019 | $3,508,000 | -68.7% | 73,500 | -78.7% | 0.12% | -79.8% |
Q3 2019 | $11,194,000 | – | 345,600 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |